Autopsy report · NCT02744690

Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia

“The necessary ethical approvals were not obtained in a timely manner.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Glaucoma

Interventions

Mitomycin-C (MMC)

Participants

0

Sites

1

Countries

Ethiopia

Trials that died the same way

• Reflective Testing for Early Diagnosis of Pituitary Dysfunction
  “Study did not require ethics Approval as it was not considered research.” (70% match in meaning)
• Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
  “No approval from ethical committee” (64% match in meaning)
• Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin
  “Not approved by the coordinating Ethical Committee” (63% match in meaning)
• Comparison of Gait in Syndesmosis Injuries Treated With Screw Fixation vs Suture Button
  “Follow-up and consent was difficult and accrual was not being met.” (61% match in meaning)
• Intra-laryngeal Implant for Treatment of Chronic Aspirations
  “The Competent Authority did not give the authorization to start the study.” (59% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.